Measles, Mumps, Rubella Vaccine Market 2030: Growth Drivers to Watch
Measles, Mumps, Rubella Vaccine Market Overview The global measles, mumps, and rubella (MMR) vaccines market was valued at USD 1.82 billion in 2024 and is projected to reach USD 2.95 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.47% from 2025 to 2030. These vaccines protect against viral infections that are particularly dangerous for non-immune pregnant women and their unborn children or newborns. A key factor driving market growth is the rising incidence of these diseases and the recurrence of outbreaks. According to data from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), measles caused an estimated 107,500 deaths globally in 2023, predominantly among children under five. Moreover, global measles cases rose by 20% between 2022 and 2023, reaching approximately 10.3 million infections. As of April 2025, the CDC reported seven measles outbreaks in the U.S.—defined as three or more linked cases—account...